Zenith Epigenetics Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zenith Epigenetics Ltd.
Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology
French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.
- Drug Discovery Tools
- Other Names / Subsidiaries
- RVX Therapeutics Inc. (previously, a subsidiary of Resverlogix Corporation)
- Zenith Epigenetics Corp.
- Zenith Epigenetics Ltd.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.